GIM
GILD icon

Grassi Investment Management’s Gilead Sciences GILD Stock Holding History

Grassi Investment Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-4,200
Closed -$324K – 115
2018
Q3 		$324K Hold
4,200
– – 0.05% 101
2018
Q2 		$298K Hold
4,200
– – 0.05% 105
2018
Q1 		$317K Sell
4,200
-530
-11% -$42.1K 0.05% 107
2017
Q4 		$339K Sell
4,730
-470
-9% -$35.7K 0.05% 116
2017
Q3 		$421K Hold
5,200
– – 0.07% 108
2017
Q2 		$368K Buy
+5,200
New +$346K 0.06% 119

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Grassi Investment Management's GILD Position: Q4 2018 in Review

Grassi Investment Management sold out of Gilead Sciences (GILD) in Q4 2018, closing a stake of 4,200 shares — an estimated $324K sold.

Grassi Investment Management first reported a position in GILD in Q2 2017 and held it in 6 quarters. The position peaked at $421K in Q3 2017. 1,496 funds tracked by Wall St. Rank hold GILD as of Q4 2018.

  • Grassi Investment Management reported no remaining Gilead Sciences position as of Q4 2018 after selling out during the quarter.
  • Grassi Investment Management sold 4,200 Gilead Sciences shares in Q4 2018, an estimated $324K.
  • Grassi Investment Management first reported a position in Gilead Sciences in Q2 2017 and held it in 6 quarters.
  • Grassi Investment Management's Gilead Sciences position peaked at $421K in Q3 2017.
  • 1,496 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2018.

Based on Grassi Investment Management's 13F filing for Q4 2018, filed 10 Jan 2019.